Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Lamzede (velmanase alfa) to Treat Alpha-Mannosidosis

Drug Name

Lamzede® (velmanase alfa)

Developer

Chiesi Group

Therapy Class

Enzyme replacement therapy

Product Description

Recombinant human alpha-mannosidase

Current Indication

Non-neurological symptoms of mild to moderate alpha mannosidosis

Market Sector

Genetics

Development Status

Approved in Europe
Expand
Close
Close
Close

Go Top